Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000647171 | SCV000768959 | benign | Dilated cardiomyopathy 1DD | 2023-12-13 | criteria provided, single submitter | clinical testing | |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV001256894 | SCV001433392 | uncertain significance | Dilated cardiomyopathy 1A | 2019-09-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002449058 | SCV002754087 | uncertain significance | Cardiovascular phenotype | 2022-11-04 | criteria provided, single submitter | clinical testing | The p.T1015I variant (also known as c.3044C>T), located in coding exon 11 of the RBM20 gene, results from a C to T substitution at nucleotide position 3044. The threonine at codon 1015 is replaced by isoleucine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV000647171 | SCV002784063 | uncertain significance | Dilated cardiomyopathy 1DD | 2021-08-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV003126891 | SCV003803454 | uncertain significance | not provided | 2023-02-06 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 26582918) |